| Q40744274 | 17Beta-estradiol is carcinogenic in human breast epithelial cells |
| Q34146321 | A common breakpoint on 11q23 in carriers of the constitutional t(11;22) translocation |
| Q30840095 | Allelotype analysis of common epithelial ovarian cancers with special reference to comparison between clear cell adenocarcinoma with other histological types |
| Q78878349 | Chromosome analysis in 31 cases of benign and malignant breast tumors: a study in Brazil |
| Q35792001 | Combined array comparative genomic hybridization and tissue microarray analysis suggest PAK1 at 11q13.5-q14 as a critical oncogene target in ovarian carcinoma |
| Q34984197 | Cytogenetics and molecular genetics of ovarian cancer |
| Q34595670 | Decreased progesterone receptor isoform expression in luteal phase fallopian tube epithelium and high-grade serous carcinoma |
| Q43947306 | Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma |
| Q37038663 | Gene products of chromosome 11q and their association with CCND1 gene amplification and tamoxifen resistance in premenopausal breast cancer |
| Q78085398 | Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2 |
| Q34230195 | HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells |
| Q43856089 | High-resolution genomic analysis of the 11q13 amplicon in breast cancers identifies synergy with 8p12 amplification, involving the mTOR targets S6K2 and 4EBP1. |
| Q73263784 | Loss of heterozygosity at chromosomes 3, 6, 8, 11, 16, and 17 in ovarian cancer: correlation to clinicopathological variables |
| Q43889975 | Loss of heterozygosity on chromosome 11 in esophageal squamous cell carcinomas |
| Q35746355 | Loss of heterozygosity on chromosome 11q22-23 in melanoma is associated with retention of the insertion polymorphism in the matrix metalloproteinase-1 promoter |
| Q34580748 | Neoplastic transformation of human breast epithelial cells by estrogens and chemical carcinogens |
| Q34207789 | OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer |
| Q34786129 | Somatic mutations of the PPP2R1B candidate tumor suppressor gene at chromosome 11q23 are infrequent in ovarian carcinomas |
| Q36161205 | The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene |
| Q41337851 | The analysis of a large Danish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 11q24. |